MOMA Therapeutics Appoints Marc Ballas as SVP, Head of Clinical Development, and Adam Thomas as Chief People and Experience Officer
Position
Chief People and Experience Officer
Company
Moma Therapeutics
CambridgeBiotechnologyHealth CareScience And EngineeringDescription
MOMA Therapeutics announces the appointments of Marc Ballas as SVP, head of clinical development, and Adam Thomas as chief people and experience officer. Dr. Ballas will oversee the company’s clinical function with the initial focus on the development of MOMA’s two lead precision oncology assets, while Mr
Quick answer
MOMA Therapeutics Appoints Marc Ballas as SVP, Head of Clinical Development, and Adam Thomas as Chief People and Experience Officer (June 25, 2024). Moma Therapeutics is based in Cambridge, Massachusetts, United States.
- Who is the new Chief People and Experience Officer at Moma Therapeutics?
- Moma Therapeutics named Adam Thomas Chief People and Experience Officer, announced June 25, 2024.
- What did Moma Therapeutics announce on June 25, 2024?
- MOMA Therapeutics announces the appointments of Marc Ballas as SVP, head of clinical development, and Adam Thomas as chief people and experience officer.
- What does Moma Therapeutics do?
- MOMA Therapeutics is committed to discovering the next generation of precision medicines by targeting molecular machines that underlie human disease.
- Where is Moma Therapeutics based?
- Moma Therapeutics is based in Cambridge, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Exscientia (June 6, 2024), Nomad Power Solutions, Inc. (June 5, 2024), Electra Therapeutics (June 3, 2024) and Haya Therapeutics (July 18, 2024) also announced leadership changes within 45 days of Moma Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Science And Engineering and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Exscientia Appoints John P. Overington as Chief Technology Officer and Marie-Louise Fjällskog, M.D., Ph.D., as Interim Chief Medical Officer (June 6, 2024)
- Lixte Biotechnology Holdings Appoints Dr. Jan Schellens as Chief Medical Officer (June 5, 2024)
- Electra Therapeutics Appoints Graham Parry as Chief Scientific Officer and Kim-Hien Dao as Chief Medical Officer (June 3, 2024)
- HAYA Therapeutics Names Eric Adam as Chief Operating Officer (July 18, 2024)
- Unlearn Appoints Steve Herne as Chief Commercial Officer (May 16, 2024)
- Zephyr AI Appoints John Applegate as Chief Financial Officer (May 16, 2024)
Who to call at Moma Therapeutics, and when
A new leader at Moma Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Moma Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Moma Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Moma Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Moma Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Moma Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.